MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)-INDUCED SYNCYTIUM FORMATION IN-VITRO - ROLE OF CELL-TO-CELL CONTACT

被引:24
作者
IDA, H [1 ]
KURATA, A [1 ]
EGUCHI, K [1 ]
YAMASHITA, I [1 ]
NAKASHIMA, M [1 ]
SAKAI, M [1 ]
KAWABE, Y [1 ]
NAKAMURA, T [1 ]
NAGATAKI, S [1 ]
机构
[1] NAGASAKI UNIV, SCH MED, DEPT INTERNAL MED 1, NAGASAKI 852, JAPAN
关键词
HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE I (HTLV-I); SYNCYTIUM FORMATION; DEXTRAN SULFATE; HEPARIN; CELL FUSION; ADHESION;
D O I
10.1016/0166-3542(94)90041-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cell-to-cell contact is usually essential for syncytium formation by HTLV-I-infected cell lines. The present study was undertaken to determine the inhibitory effect of polyanionic compounds, dextran sulfate and heparin, on HTLV-I-induced syncytium formation, as demonstrated by the fusion of HTLV-I-infected cells with target cells. These two compounds almost completely blocked syncytium formation in the early phase of the reaction at a concentration of 125 mu g/ml, but dextran, as a control, did not inhibit it at concentrations up to 625 mu ug/ml. 50% inhibition of syncytium formation was detected at a concentration of 2 mu g/ml of dextran sulfate 5000, 3 mu g/ml of dextran sulfate 8000 and 8 mu ug/ml of heparin. The binding of radiolabeled HTLV-I-infected cells (HCT-1) to the target cells was inhibited by addition of dextran sulfate and heparin, and the inhibitory effects were concentration-dependent. No marked changes were detected in the expression of adhesion molecules on the virus-infected cells and target cells, and in the expression of envelope proteins on the virus-infected cells after exposing them to the polyanionic compounds. These results suggest that the blocking of cell-to-cell contact by polyanionic compounds, probably independent of surface adhesion molecules, is important for their inhibitory effect on HTLV-I-induced syncytium formation.
引用
收藏
页码:143 / 159
页数:17
相关论文
共 52 条
[1]   ORAL DEXTRAN SULFATE (UA001) IN THE TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX [J].
ABRAMS, DI ;
KUNO, S ;
WONG, R ;
JEFFORDS, K ;
NASH, M ;
MOLAGHAN, JB ;
GORTER, R ;
UENO, R .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (03) :183-188
[2]   NOVEL SULFATED POLYMERS AS HIGHLY POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION AND GIANT-CELL FORMATION [J].
BABA, M ;
SCHOLS, D ;
DECLERCO, E ;
PAUWELS, R ;
NAGY, M ;
GYORGYIEDELENYI, J ;
LOW, M ;
GOROG, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :134-138
[3]   MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
ARNOUT, J ;
DESMYTER, J ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136
[4]   SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
BABA, M ;
SNOECK, R ;
PAUWELS, R ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745
[5]   DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[6]   PRODUCTIVE INFECTION AND CELL-FREE TRANSMISSION OF HUMAN T-CELL LEUKEMIA-VIRUS IN A NON-LYMPHOID CELL-LINE [J].
CLAPHAM, P ;
NAGY, K ;
CHEINGSONGPOPOV, R ;
EXLEY, M ;
WEISS, RA .
SCIENCE, 1983, 222 (4628) :1125-1127
[7]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[9]   INVESTIGATIONS ON PLASMA ACTIVITY OF LOW-MOLECULAR WEIGHT HEPARIN AFTER INTRAVENOUS AND ORAL ADMINISTRATIONS [J].
DRYJSKI, M ;
SCHNEIDER, DE ;
MOJAVERIAN, P ;
KUO, BS ;
BJORNSSON, TD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (02) :188-192
[10]   PHARMACOKINETICS, TOXICITY, AND ACTIVITY OF INTRAVENOUS DEXTRAN SULFATE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
FLEXNER, C ;
BARDITCHCROVO, PA ;
KORNHAUSER, DM ;
FARZADEGAN, H ;
NERHOOD, LJ ;
CHAISSON, RE ;
BELL, KM ;
LORENTSEN, KJ ;
HENDRIX, CW ;
PETTY, BG ;
LIETMAN, PS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2544-2550